Matthias Wiedenfels
Consultant
Frankfurt
Introduction
Matthias is a former pharmaceutical CEO turned corporate consultant advising on healthcare M&A, takeovers, compliance and corporate governance with deep industrial and transactional knowledge.
Dr. Matthias Wiedenfels is a consultant in our corporate practice.
Matthias is our industrial authority in our global healthcare practice and advises on takeover situations, M&A transactions and on all pharmaceutical and healthcare matters.
He is knowledgeable in corporate governance, corporate strategy, compliance, corporate law and pharma law. As the former CEO of STADA Arzneimittel AG, he played a decisive role in the takeover of the company by Bain Capital and Cinven, and in many other major transactions.
As a co-author of the "Pharma und Life Science" handbook, Matthias is a recognised for pharma law and for compliance.
With his industrial and transactional experience and his management know-how, Matthias is strengthening our corporate and healthcare advisory practice for our clients. Beside his consultancy role for Ashurst Perkins Coie, Matthias is an investor and entrepreneur in the healthcare market.
Matthias studied law in Heidelberg, Montpellier and Freiburg. He was admitted to bar in 2001 and published a multitude of professional articles and handbooks. He speaks English and French and is an advisory board member on various national and international companies.
Areas of focus
Latest thinking
Carousel: clicking the "Previous" or "Next" button changes the content between the buttons.
